MegaPro Biomedical MPB-1734 Receives Composition Patent for

DJ MegaPro Biomedical MPB-1734 Receives Composition Patent for New Dosage Form of Anticancer Drug which enhanced the immune-combination therapy EQS Newswire / 15/11/2022 / 10:41 UTC+8 MegaPro Biomedical

Related Keywords

Taiwan , United States , Industrial Technology Research Institute , Kao Hsiung , Kostenloser Wertpapierhandel , Marketing Press , Megapro Biomedical Receiving Compositional Patent , Megapro Biomedical Co Ltd , Composition Patent , New Dosage Form , Anticancer Drug , Pro Biomedical , Press Release , Yuan Hung Hsu , Executive Vice President , Megapro Biomedical , Industrial Technology Research , Marketing Press Release , Dow Jones Newswires , Omegapro , Iomedical , 4734 , Eceives , Composition , Patent , Dosage , Form , Anticancer , Drug , Which , Nhanced , Immune , Combination , Therapy ,